The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
Andrew Walker
Advertisement
Andrew Walker is vice president, device development, Vectura.
Articles by Andrew Walker
Advertisement
Latest Updated Articles
Integrated Approach Facilitates Inhalation Drug DevelopmentPublished: August 1st 2021 | Updated:
Advertisement
Advertisement
